 |
David Ferrera
With oral arguments due to be heard Monday in the Supreme Court case of Wyeth v. Levine, the issues of drug makers' liability in patient injuries and the FDA's role in consumer safety are front and center. (Full article: 733 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
